EF
IONS icon

Empowered Funds’s Ionis Pharmaceuticals IONS Stock Holding History

Empowered Funds’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7M Buy
223,142
+120,001
+116% +$9.03M 0.09% 227
2026
Q1 		$7.74M Buy
+103,141
New +$8.14M 0.05% 482
2025
Q3 		– Sell
-5,067
Closed -$200K – 1887
2025
Q2 		$200K Buy
+5,067
New +$166K ﹤0.01% 1648

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Empowered Funds's IONS Position: Q2 2026 in Review

Empowered Funds increased its Ionis Pharmaceuticals (IONS) stake by 116% in Q2 2026, buying an estimated $9.03M and bringing the position to 223,142 shares worth $17.7M. The position accounts for 0.09% of the portfolio, ranked #227.

Empowered Funds first reported a position in IONS in Q2 2025 and has held it in 3 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Empowered Funds held 223,142 shares of Ionis Pharmaceuticals worth $17.7M as of Q2 2026.
  • Empowered Funds bought 120,001 Ionis Pharmaceuticals shares in Q2 2026, an estimated $9.03M.
  • Ionis Pharmaceuticals made up 0.09% of Empowered Funds's portfolio in Q2 2026, its #227 holding.
  • Empowered Funds first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.